GSK Consumer profit increases by 35%

NEW DELHI: Glaxo Smith Kline (GSK) Consumer Healthcare Ltd on Thursday reported a 35.07 per cent increase in its standalone profit to Rs 221.06 crore for the quarter ended December 2018. It had posted a profit of Rs 163.66 crore for the October-December period a year ago. The company's total income stood at Rs 1,241.07 crore, up 12.82 per cent, as against Rs 1,100.02 crore in the year-ago period, GSK Consumer Healthcare said in a BSE filing. "We have been witnessing healthy sustainable growth in our financial performance in the past few quarters. This growth is reflective of the unflinching trust that our consumers have in our products," GlaxoSmithKline Consumer Healthcare Managing Director Navneet Saluja said. On December 3, 2018, the company had announced divestment of Horlicks and other consumer healthcare nutrition brands to Unilever plc and the merger of GSK Consumer Healthcare with Hindustan Unilever Limited (HUL).